Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Time series are combined where methods are similar over the time span, this is less clear for UK where the trend may therefore be less reliable. Spain and Luxembourg each have two different time series. For more details see Table PDU-1 to Table PDU-3. Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. In some countries data are insufficient to report. The estimates of Czech Republic refer to the age group 18-64.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
National Focal Points. See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.europa.eu/?nnodeid=1372).